FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
Hibi M, Kaneda H, Tanizaki J, Sakai K, Togashi Y, Terashima M, De Velasco MA, Fujita Y, Banno E, Nakamura Y, Takeda M, Ito A, Mitsudomi T, Nakagawa K, Okamoto I, Nishio K.
Hibi M, et al. Among authors: nishio k.
Cancer Sci. 2016 Nov;107(11):1667-1676. doi: 10.1111/cas.13071.
Cancer Sci. 2016.
PMID: 27581340
Free PMC article.